
News|Articles|June 1, 2002
Part 2: Beyond depression: Evaluation of newer indications and off-label uses for SSRIs (PDF)
In this final installment of this series, the authors focus on the use of SSRIs in alcohol dependence, chronic pain, eating disorders, premenstrual dysphoric disorder, and sexual dysfunction. For each condition, the authors examine how well clinical trial evidence supports the application, discuss dosing and safety considerations, and provide their recommendations on preferred and alternative SSRIs, based on the weight of the evidence.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
2025 FDA added indications to dermatologic medications
2
Immune system targets single beta cells before Type 1 diabetes symptoms show
3
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
4
A look back at 2025’s sunscreen controversy and confusion
5

















































